• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Culture?







Compensation is horrible compared to industry standards. No ability to do lunches. Company is super cheap when it comes to expenses. If you’re trying to break into device, do it for year and move on. If you are already in device it’s a hard pass.